Srinivas Akkaraju - Aug 18, 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role: Director
Signature: /s/ Srinivas Akkaraju
Stock symbol: KDNY
Transactions as of: Aug 18, 2021
Transactions value $: $2,497,830
Form type: 4
Date filed: 8/20/2021, 05:37 PM
Previous filing: Jun 10, 2021
Next filing: Aug 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KDNY	Common Stock	Purchase	$2.5M	+209K	+6.58%	$11.98	3.38M	Aug 18, 2021	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These purchases were executed in multiple trades at prices ranging from $11.50 to $12.00. The price reported above reflects the weighted average purchase price. Mr. Akkaraju hereby undertakes to provide full information regarding the number of shares and prices at which these purchases were effected, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.
F2	Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest therein.

Content

These purchases were executed in multiple trades at prices ranging from $11.50 to $12.00. The price reported above reflects the weighted average purchase price. Mr. Akkaraju hereby undertakes to provide full information regarding the number of shares and prices at which these purchases were effected, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest therein.